Our CTD-1 molecule presents a synergistic approach to improving immunology treatment through its enhanced anti-tumor immune responses and reduced inflammation within the tumor microenvironment.
#worldorphanUSA #biotech #lifescience #raredisease
gtsbiotech.com/post/advancin…
